Regulation of gut-derived resistin-like molecule β expression by nutrients

Diabetes Research and Clinical Practice

Volumn 79, Issue 1, 2008, Pages 2-10

  Fujio, Junko ^a   Kushiyama, Akifumi ^a   Sakoda, Hideyuki ^a   Fujishiro, Midori ^a   Ogihara, Takehide ^b   Fukushima, Yasushi ^a   Anai, Motonobu ^c   Horike, Nanao ^a   Kamata, Hideaki ^d   Uchijima, Yasunobu ^a   Kurihara, Hiroki ^a   Asano, Tomoichiro ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c INSTITUTE FOR ADULT DISEASES   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Insulin resistance; Nutrient compositions; RELM

Indexed keywords

FATTY ACID; INSULIN; MESSENGER RNA; RESISTIN; RESISTIN LIKE MOLECULE ALPHA; RESISTIN LIKE MOLECULE BETA; RESISTIN LIKE MOLECULE GAMMA; STEARIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CANCER CELL CULTURE; CARBOHYDRATE DIET; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DISEASE MODEL; EPIDIDYMIS FAT; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; INTESTINE; LIPID DIET; MOUSE; NONHUMAN; NUTRIENT; PROTEIN DIET; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMAL FEED; ANIMALS; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; EATING; FASTING; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION; GLUCOSE; HORMONES, ECTOPIC; INTESTINES; MICE; MICE, INBRED C57BL; RESISTIN; RNA, MESSENGER; STEARIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37549045965     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.04.015     Document Type: Article

References (27)

1. Steppan C.M., Brown E.J., Wright C.M., Bhat S., Banerjee R.R., Dai C.Y., et al. A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 502-506
2. Gerstmayer B., Kusters D., Gebel S., Muller T., Van Miert E., Hofmann K., et al. Identification of RELMgamma, a novel resistin-like molecule with a distinct expression pattern. Genomics 81 (2003) 588-595
3. Holcomb I.N., Kabakoff R.C., Chan B., Baker T.W., Gurney A., Henzel W., et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19 (2000) 4046-4055
4. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
5. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., et al. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
6. Way J.M., Gorgun C.Z., Tong Q., Uysal K.T., Brown K.K., Harrington W.W., et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 276 (2001) 25651-25653
7. Milan G., Granzotto M., Scarda A., Calcagno A., Pagano C., Federspil G., et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes. Res. 10 (2002) 1095-1103
8. Juan C.C., Au L.C., Fang V.S., Kang S.F., Ko Y.H., Kuo S.F., et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem. Biophys. Res. Commun. 289 (2001) 1328-1333
9. Nagaev I., and Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem. Biophys. Res. Commun. 285 (2001) 561-564
10. Kim K.H., Lee K., Moon Y.S., and Sul H.S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem. 276 (2001) 11252-11256
11. Liu T., Jin H., Ullenbruch M., Hu B., Hashimoto N., Moore B., et al. Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6. J. Immunol. 173 (2004) 3425-3431
12. Chumakov A.M., Kubota T., Walter S., and Koeffler H.P. Identification of murine and human XCP1 genes as C/EBP-epsilon-dependent members of FIZZ/resistin gene family. Oncogene 23 (2004) 3414-3425
13. Schinke T., Haberland M., Jamshidi A., Nollau P., Rueger J.M., and Amling M. Cloning and functional characterization of resistin-like molecule gamma. Biochem. Biophys. Res. Commun. 314 (2004) 356-362
14. He W., Wang M.L., Jiang H.Q., Steppan C.M., Shin M.E., Thurnheer M.C., et al. Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology 125 (2003) 1388-1397
15. Artis D.W.M., Keilbaugh S.A., He W., Brenes M., Swain G.P., Knight P.A., Donaldson D.D., et al. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13596-13600
16. Shojima N., Ogihara T., Inukai K., Fujishiro M., Sakoda H., Kushiyama A., et al. Serum concentrations of resistin-like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow. Diabetologia 48 (2005) 984-992
17. Kushiyama A., Shojima N., Ogihara T., Inukai K., Sakoda H., Fujishiro M., et al. Resistin like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes and induces diabetes, hyperlipidemia and fatty liver in transgenic mice on a high-fat diet. J. Biol. Chem. 280 (2005) 42016-42025
18. Krutzik S.R., Ochoa M.T., Sieling P.A., Uematsu S., Ng Y.W., Legaspi A., et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 9 (2003) 525-532
19. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 106 (2000) 473-481
20. Rajala M.W., Obici S., Scherer P.E., and Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Invest. 111 (2003) 225-230
21. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001) 1343-1350
22. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 (2002) 393-403
23. Franz M.J., Bantle J.P., Beebe C.A., Brunzell J.D., Chiasson J.L., Garg A., et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 26 Suppl. 1 (2003) S51-S61
24. The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), 1999, Recommendations for the nutritional management of patients with diabetes mellitus, Eur. J. Clin. Nutr. 54 (2000) 353-355.
25. McAuley K.A., Smith K.J., Taylor R.W., McLay R.T., Williams S.M., and Mann J.I. Long-term effects of popular dietary approaches on weight loss and features of insulin resistance. Int. J. Obes. (Lond) (2005) 342-349
26. Nuttall F.Q., and Gannon M.C. Metabolic response of people with type 2 diabetes to a high protein diet. Nutr. Metab. (Lond) 1 (2004) 6
27. Suganami T.N.J., and Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor-alpha. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2062-2068